Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/305% below fair value
$36.18−0.40 (-1.09%)
Close on Nov 13, 2026Market cap $2.78BP/E 33.2Yield –
Progyny enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Progyny's enterprise value was $2.59B on Nov 11, 2026, against $1.93B a year earlier. Over the last 5 years it ranged from $1.10B to $4.56B, with a median of $2.56B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.59B | +38.6% |
| 2025 | Dec 31, 2025 | $1.87B | +44.9% |
| 2024 | Dec 31, 2024 | $1.29B | -60.1% |
| 2023 | Dec 29, 2023 | $3.22B | +17.5% |
| 2022 | Dec 30, 2022 | $2.74B | -37.9% |
| 2021 | Dec 31, 2021 | $4.42B | +24.0% |
| 2020 | Dec 31, 2020 | $3.56B | +1229.1% |
| 2019 | Dec 31, 2019 | $268.12M | – |
See a number that looks wrong?